Results 61 to 70 of about 354 (165)
Introduction: Currently, chronic heart failure (CHF) is one of the leading problems of modern healthcare. Its most common manifestation is the deterioration of the inotropic reserves of the heart muscle, which over time leads to decompensation and damage
Valentin Kataev +8 more
doaj +1 more source
In total, 149 patients, aged 41–75 years, with Functional Class (FC) II-III stable angina, who underwent coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI), were examined.
I. G. Gordeev +2 more
doaj
Solid herbal extract of Primula veris L. improves morphofunctional condition of rats' myocardium in chronic alcohol intoxication. [PDF]
Prokofiev II +9 more
europepmc +1 more source
Unlocking the Potential of Meldonium: From Performance Enhancement to Therapeutic Insights
Meldonium, a promising pharmacological agent initially developed for cardiovascular indications, has sparked considerable interest in recent years due to its potential performance-enhancing effects.
Val Bellman
doaj +1 more source
Inhibition of mitochondrial fatty acid β-oxidation activates mTORC1 pathway and protein synthesis via Gcn5-dependent acetylation of Raptor in zebrafish. [PDF]
Zhou WH +8 more
europepmc +1 more source
MAIN THERAPEUTIC PRINCIPLES IN PREMENOPAUSAL WOMEN
The review outlines the main mechanisms of protective estrogen effects on cardiovascular system and the role of estrogen deficiency in cardiovascular disease (CVD) development. The position of the International Menopause Society (2009) on CVD in women is
S. N. Tolstov +5 more
doaj
Mildronate (meldonium): First, do no harm
Meldonium (Mildronate) is used as a cardioprotective drug; however, it has not been officially approved anywhere outside the former Soviet Union (SU). The supposed action mechanism is based on the carnitine (Lcarnitine) lowering effect in muscular and cardiac tissues.
openaire +1 more source
In total, 100 patients aged 45-70 years, with Functional Class (FC) II-III chronic heart failure (CHF) and compensated or sub-compensated Type 2 diabetes mellitus (DM-2) were examined.
M. E. Statsenko +4 more
doaj
Оn-pump coronary bypass surgery was performed in 58 stable angina patients aged 43-72. Group I (n = 19) received standard coronary heart disease (CHD) treatment, together with mildronate: before the surgery, 750 mg/d for 3 days, then 750 mg/d twice a ...
I. G. Gordeev +5 more
doaj
CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma. [PDF]
Wang J +10 more
europepmc +1 more source

